Akcea And Pfizer Inc. Announce Licensing Agreement For Investigative Antisense Therapy Akcea-angptl3-lrx

Boston, Mass. and New York, NY, (STL.News) – Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) and Pfizer Inc. (NYSE:PFE), today announced that the…

The post Akcea And Pfizer Inc. Announce Licensing Agreement For Investigative Antisense Therapy Akcea-angptl3-lrx appeared first on STL.News.